Acuamark Diagnostics, Inc. announced it raised $11.6 Million in an initial filing from an offering of $13.6 Million

Company

Location

About

Acuamark Diagnostics develops technology to allow for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced scientific team, it is Acuamark Diagnostics' mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.